When it comes to massage chairs in the U.S. market, few names carry the sheer product weight of Osaki, a Texas-based powerhouse known for its immense lineup, feature stacking, and aggressive pricing. Zarifa USA, on the other hand, plays a different game — one rooted in therapeutic wellness, veteran support, and a smaller portfolio of clinically oriented chairs designed to appeal to users with specific recovery goals or chronic pain conditions. While Osaki targets everyone from budget-seekers to luxury shoppers, Zarifa speaks more directly to people who are looking for FDA-registered therapy tools, military-grade approval, and compact, accessible equipment.

While Zarifa doesn’t currently operate in the $9,000+ luxury tier that Osaki dominates, its mid-tier and entry-level models are heavily promoted within wellness and recovery circles — especially among older adults and veterans. So the question becomes: Does therapy focus beat out feature density when it comes to daily use?
Conclusion
Osaki is still the dominant force in the American massage chair landscape — delivering feature-packed, aggressively priced models across every tier, with strong tech, strong customization, and solid durability.
But Zarifa USA makes a compelling case for therapeutic simplicity. Its recovery-first philosophy, streamlined models, and accessible controls make it an ideal choice for users seeking clinical wellness benefits without a steep learning curve. While it can’t compete with Osaki on feature count or roller tech, it holds its own in comfort, affordability, and user trust — especially for buyers focused on health and relief.